Cite
HARVARD Citation
Apalla, Z. et al. (2022). European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement. Journal of the European Academy of Dermatology and Venereology. pp. 332-350. [Online].